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Metastasis is a multistep process, during which circulating tumor cells traffic through diverse anatomical locations. Stable
inducible marking of tumor cells in a manner that is tightly spatially and temporally controlled would allow tracking the
contribution of cells passing through specific locations to metastatic dissemination. For example, tumor cells enter the
lymphatic system and can form metastases in regional lymph nodes, but the relative contribution of tumor cells that traffic
through the lymphatic system to the formation of distant metastases remains controversial. Here, we developed a novel
genetic switch based on mild transient warming (TW) that allows cells to be marked in a defined spatiotemporal manner
in vivo. Prior to warming, cells express only EGFP. Upon TW, the EGFP gene is excised and expression of mCherry is
permanently turned on. We employed this system in an experimental pancreatic cancer model and used localized TW to induce
the genetic switch in tumor cells trafficking through tumor-draining lymph nodes. Thereby we found that tumor cells
disseminating via the lymphatics make a major contribution to the seeding of lung metastases. The inducible genetic marking
system we have developed is a powerful tool for the tracking of metastasizing cells in vivo.
Introduction
Cancer cells disseminating from primary tumors pass through
different conduits and anatomical sites, which can affect the
outcome of the metastatic process.1 Dissecting the contribu-
tion of cells that traffic through distinct locations at specific
points in time requires their labeling in a precise spatiotempo-
ral manner, ideally using an inducible genetic switch that can
permanently mark the disseminating cells. Current inducible
gene expression systems typically employ soluble inducers,
such as tetracycline/doxycycline or (4-hydroxy)tamoxifen.2
While such treatments allow temporal control of gene expres-
sion, spatial restriction of the induction is difficult to achieve,
due to diffusion and systemic distribution of the inducer.
Leakiness due to basal promoter activity is also often a prob-
lem. High spatiotemporal precision of cell labeling can be
achieved using phototransformation of fluorescent proteins
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after exposure to light of specific wavelength.3,4 However,
turnover of the phototransformed proteins means that cells
labeled with them cannot be followed for more than a few
days, which is insufficient for comprehensive characterization
of tumor progression and metastasis.
Physical stimuli such as temperature modulation represent
an alternative approach. Increased temperature activates tran-
scription factors of the heat shock factor (HSF) family, which
transactivate heat shock elements (HSEs) in the promoters of
heat-sensitive genes, including heat-shock protein genes.5
Such promoters are activated rapidly and efficiently in
response to heat.6,7 Importantly, in addition to precise tempo-
ral control, heat-responsive promoters can also be regulated in
a spatially defined manner. This can be achieved by targeted
application of electromagnetic radiation or focused ultrasound
to deeper tissues, or via direct contact with a heat source for
more superficially located targets.8
One important question that can be addressed through
precise spatiotemporally controlled tumor cell labeling is the
contribution of cells that traffic through lymph nodes to the
formation of metastases. Tumor cells that disseminate via the
lymphatics first pass through the lymph nodes (LNs) that
drain the primary tumor. These cells may establish metastases
in the LNs, or pass through them and continue to disseminate
hematologically either by invading LN blood vessels4,9 or by
trafficking through the efferent lymphatics that empty into the
blood circulation, for example via the thoracic duct. Similarly,
established LN metastases may conceivably shed tumor cells
into the blood system, either through the efferent lymphatics
or through blood vessels within the LN. However, the degree
to which tumor cells that disseminate via the lymphatic sys-
tem contribute to metastasis formation in distant organs is
insufficiently understood. LN metastases have been seen as
potential reservoirs of tumor cells that could seed further
metastases, and LNs regional to primary tumors have been
surgically removed for decades with the aim of improving
patient survival.10 Furthermore, the expression of factors in
primary tumors that stimulate lymphangiogenesis, such as
VEGF-C, often correlates with LN metastasis formation and
poor prognosis.10 However, the contribution of tumor cells
that traffic via the lymphatics to metastasis formation in vital
organs remains controversial. A long-standing notion is that
LNs may act as filters that impede the further passage of
tumor cells.11 Moreover, many long-term randomized trials
have failed to demonstrate that dissection or irradiation of
LNs beyond the sentinel LNs has significant benefit for overall
patient survival.12–17
Together, these observations underline the need for methods
that accurately track the fate of tumor cells that traffic through
the lymphatics, and permit their contribution to metastasis for-
mation in vital organs to be evaluated. To address this issue, we
report here a genetic tracking method that allows the fate of
tumor cells trafficking through LNs in vivo to be assessed. In this
method, tumor cells disseminating via the lymphatics are perma-
nently marked in vivo through a switch in expression of green
fluorescent protein to a red fluorescent protein, allowing their fate
and behavior to be tracked. In a proof of principle experiment
using a pancreatic cancermodel, we found that a large proportion
of lung metastases were seeded by tumor cells that had trafficked
via the lymphatics.
Materials and Methods
Cell culture, transfection and stable tumor cell lines
The rat pancreatic carcinoma cell line BSp73-ASML, as well as
the rat mammary carcinoma cell lines MT-450 and MTLy were
maintained as described previously.18 ASML-TWIGS cells were
obtained by cotransfection of the HSP-Cre-IRES-Luc construct
with a puromycin resistance plasmid using Lipofectamine 2000
(Thermo Fisher Scientific, Waltham, MA). Resistant clones were
selected for luciferase induction 3 hr after TW, then cotransfected
with the floxed EGFP-mCherry reporter construct and a neomy-
cin resistance plasmid. Resistant clones with EGFP expression
were picked and tested for switching to mCherry expression
after TW. B16-F10 (RRID:CVCL_0159) and MCF-7 (RRID:
CVCL_0031) cells were purchased from ATCC and cultured in
DMEM with 10% FBS, 1% penicillin/streptomycin at 37C with
5% CO2. B16-F10 cells were transfected with 5 μg HSPmin-Luc
plasmid and 20 μl Lipofectamine 2000 and MCF-7 cells were
transfected with 3 μg HSPmin-Luc plasmid and 10 μl FuGENE
HD (Promega) in 6 cm plates, according to the manufacturer’s
instructions. MCF-7 cells were authenticated within the last
3 years by CLS Cell Lines Service (Eppelheim, Germany) using
STR profiling. Experiments were performed with mycoplasma-
free cells.
Cloning
Cloning of the HSPmin element. A 172 bp long fragment of
the rat heat shock 70 kDa protein 1B (Hspa1b) promoter was
What’s new?
Tracking tumor cells as they move through tissues on their way to colonizing distant organs can provide important insight into
the metastatic process. Methods to accurately track tumor cell movement, particularly through the lymphatic system, however,
have been lacking. Here, the authors developed a novel system employing a genetic switch from green fluorescent protein
expression to red fluorescent protein expression to track tumor cells in an in vivo model. The switch, induced in a spatio-
temporally controlled manner by mild transient warming, permanently marked tumor cells, allowing the cells to be successfully
followed through the lymphatics to their final destinations.
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amplified by PCR with HSP-forward 50-CAAGGGCGGTACCC
TCAACATGG-30 and HSP-reverse 50-GGAATCTGGTGTCC
TGCGCGCCG-30 primers from rat genomic DNA, cloned into
pCR2.1 (Topo-Cloning Kit, Invitrogen), then subcloned into the
SacI/NotI sites of pBluescript to create the HSP-pBluescript
construct.
Cloning of HSPmin-Luc. The HSPmin element was cut out of
pCR2.1-Topo by HindIII and XhoI and ligated into the Hin-
dIII /XhoI sites of the promoterless luciferase reporter pXP2.
Cloning of HSP-Cre-IRES-Luc. The Cre open reading frame
(ORF) of pPGK-Cre-bpA (kind gift from Kurt Fellenberg)
was excised using XhoI and ligated into the XhoI site of HSP-
pBluescript behind the HSPmin element creating the HSP-Cre
construct. The HSPmin element-Cre portion of pBluescript-
HSP-Cre was isolated after SacI digestion and blunt-ended.
The mammalian expression vector MMTV-IRES-Luc (kind
gift from Gerhard Christofori) was digested with SacI and PstI
to remove the MMTV promotor. The residual vector was
blunt-ended and ligated with the blunt-ended HSPmin
element-Cre fragment.
Cloning of floxed-EGFP/mCherry. The mammalian expres-
sion vector pCall2-updated (kind gift from Gerhard Christo-
fori) uses the ubiquitous CMV-IE-chicken β actin promoter to
drive expression of a floxed β-Geo gene followed by EGFP.
This vector was cut with XhoI and NotI to excise the EGFP
cassette, then the residual vector was blunt-ended and rec-
ircularized (pCall2-updated ΔEGFP construct). Next, the
EGFP cassette in pEGFP-N1 (Clontech) was amplified by
PCR using ClaI-EGFP 50-GGCATCGATCCACAACCATGGT
GAGCAAGGGCGAGGAGCTG-30 and EGFP-SphI 50-GGCG
CATGCTTACTTGACAGCTCGTCCATGCCGAGAGTGAT
CCC-30 primers. The following cycling conditions were used:
3 min 94C, 1 min 94C; 1.5 min 72C 30×; 10 min 72C. The
750 bp PCR product was digested with ClaI and SphI, and
ligated into pCall2-updated ΔEGFP digested with ClaI and
SphI, thereby replacing the β-geo gene with the EGFP cassette
followed by a stop codon at the end of the coding sequence
and three tandem polyadenylation signals to create the
pCall2-updated ΔEGFP Δβ-geo EGFP construct. Finally, the
open reading frame of the mCherry fluorescent protein was
amplified from pcDNA3.1 mCherry (kind gift from Marcus
Diefenbacher) by PCR using BglII-mCherry 50-GACAGATC
TGCCACCATGGTGAGCAAGGGCGAGGAGCTG-30 and
Cherry-stop-XhoI 50-GACCTCGAGTCAACCCTCGTACA
GCTCGTCCATGCCGAGAGTGATC-30 primers. The fol-
lowing cycling conditions were used: 3 min 94C; 1 min 94C;
1.5 min 72C 30×; 10 min 72C. The 800 bp PCR-product was
digested with BglII and XhoI and ligated into the BglII/XhoI
sites of the pCall2-updated ΔEGFP Δβ-geo EGFP construct to
create the floxed EGFP-mCherry reporter construct.
All constructs were verified by sequencing.
Transient warming in vitro and luciferase assays
TW of cell suspensions (100 μl) for luciferase assays were per-
formed in a PCR machine for 10 min at the indicated test
temperature. Cells were then processed for luciferase assays.
For luciferase assays using cell lysates, lysates were prepared
on ice for 10 min with a lysis buffer containing 0.1 M Tris pH 7.5,
2 mM EDTA, 1% Triton X-100. Lysate aliquots of 20 μl were
transferred in a 96-well assay plate and analyzed in a lumines-
cence reader (VicorLight, Perkin Elmer). Before each measure-
ment, an automated dispenser added 70 μl assay buffer per well
(1 mM DTT, 1 mM ATP, 25 mM glycylglycine, 15 mM MgSO4,
4 mM EGTA), followed by 20 μl substrate buffer (200 μM lucif-
erin, 25 mM glycylglycine, 15 mMMgSO4, 4 mM EGTA). Alter-
natively, luciferase assays were performed using the above lysis
buffer and reagents from the Luciferase Assay System (Promega,
E1500) with a Spark microplate reader (Tecan). The luciferase
signal (count/s) was normalized per μg of total protein in the
lysates, as determined using the Pierce BCA Protein Assay
(Thermo Fisher Scientific).
For luciferase assays with living cells to determine lucifer-
ase expression kinetics after TW, cells were seeded in triplicate
in 96-well ViewPlates (Greiner Bio-One, Kremsmünster, Aus-
tria) and luciferin-K+ salt (Biosynth, Itasca, IL) was added to a
final concentration of 0.5 mM. The plates were sealed with a
translucent foil and placed in a luminometer (EnVision,
Perkin Elmer, Waltham, MA) at 37C. Measurements were
taken every 15 min (as indicated) for 24 hr. Measurements
were expressed in counts per second.
Tumor experiments and TW in vivo
All studies were approved by the local Ethical Review Board.
Unless otherwise indicated, groups of eight male 8–9 weeks
old RNU/RNU rats (Charles River, Wilmington, MA) were
injected subcutaneously in the flank with 1 × 106 ASML-
TWIGS cells in PBS per rat. Animals were then either left
untreated or received one daily TW of the axillary LN ipsilat-
eral or contralateral to the primary tumor from Day 1 after
tumor cell injection until day 32 (see Supporting Information
for details). Tumor size was measured with a caliper. Tumor
volume was calculated using the formula π/6 × L × W × H,
where L, W and H are length, width and height, respectively.
The rats were sacrificed 32 days after injection of tumor cells
or when tumor volumes reached the maximum permitted size.
Primary tumors, axillary LNs and lungs were fixed in formalin
and paraffin-embedded for histological analyses.
Quantification of lung metastases
Macrometastases >0.1 mm in diameter on the surface of
unfixed lung lobes were evaluated using an epifluorescence
stereomicroscope (Leica). Metastases in which only EGFP-
expressing cells were present were scored as EGFP+; metasta-
ses in which only mCherry-expressing cells or a mixture of
EGFP− and mCherry-expressing cells were present were
scored as mCherry+.
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Paraffin sections were deparaffinized and enzymatic antigen
retrieval was performed by incubation with 1.25 μg/ml Pro-
teinase K (Roth, Karlsruhe) in TE buffer. EGFP-staining was
done overnight at 4C with 1.25 μg/ml anti-EGFP-antibody
(polyclonal, #632376 Clontech) followed by incubation with
an Alexa-488 labeled secondary antibody (4 μg/ml goat-anti-
rabbit-F(ab‘)2, Dako, Glostrup Denmark) for 1 hr. Prior to
mCherry staining, endogenous biotin was blocked using the
Biotin Blocking System Kit (Dako, Glostrup Denmark). After
blocking, the slides were incubated with 10 μg/ml biotin-
labeled anti-RFP-antibody (polyclonal, Abcam ab34771) at
4C overnight, then stained with 5 μg/ml Alexa-546 labeled
streptavidin (Invitrogen, Karlsruhe) in TBS for 2 hr at room
temperature. Nuclear staining was performed by incubation
with 2 μg/ml Hoechst-33342 (Invitrogen, Karlsruhe) in water
for 7 min. Cover slips were mounted with Mowiol 4–88
(Roth, Karlsruhe).
Statistics
Error bars indicate standard error of the mean. When two
groups were compared, a two-sided Student’s t-test was used.
For multiple comparisons, one-way ANOVA was used with
Bonferroni post hoc tests for pairwise comparisons (GraphPad
Prism). For comparing the proportions of metastases generated
by EGFP+ and mCherry+ cells, pairs of treatments were com-
pared using the Chi-square test (GraphPad Prism). Statistical
significance is indicated by asterisks: *p < 0.05; **p < 0.01; ***
p < 0.001.
Data availability
The data that support the findings of our study are available
from the corresponding author upon reasonable request.
Results
Development of a green–red fluorescent protein genetic
switch triggered by TW
To develop an inducible system for marking disseminating
tumor cells in a spatiotemporally controlled manner, we first
created a promoter element that can be activated by
TW. Heat-regulated promoters are generally also activated by
other stress factors found within tumors such as hypoxia.19
To create a promoter that is induced specifically in response
to TW but not hypoxia, we used a sequence of the rat HSP70
promoter containing a single heat shock response element
(HSE I), which has been reported to show very little induction
after hypoxia.20 This minimal HSP70 promoter (HSPmin) was
cloned in front of a luciferase reporter (HSPmin-Luc) to allow
its activity to be characterized (Fig. 1a, top).
The HSPmin promoter was then used to create a Transient
Warmth Inducible Genetic Switch (TWIGS) system, con-
sisting of two plasmids (Fig. 1a, bottom). In the first construct
(HSP-Cre-IRES-Luc), the HSPmin promoter drives expression
of Cre recombinase, as well as luciferase via an internal
ribosome entry site (IRES). The second construct (floxed
EGFP/mCherry) uses a strong constitutive CMV/β-actin pro-
moter to drive expression of a floxed EGFP, which is followed
by mCherry. At 37C, cells transfected with the two TWIGS
constructs only express EGFP. TW induces Cre expression,
leading to excision of the floxed EGFP cassette and the
switching on of mCherry expression.
MT450, ASML and MTLy tumor cell lines were stably
transfected with HSPmin-Luc. ASML cells were also stably
transfected with the TWIGS constructs. The cells were then
subjected to various temperatures between 37C and 44C for
10 min. Luciferase reporter assays showed that the optimal
activation temperature for the HSPmin element is around
43–43.5C (Fig. 1b). After TW (hereafter defined as 10 min
warming to 43.5C), transactivation by the HSPmin element
in living cells peaked at around 2 hr and returned to basal
levels by 12 hr post-TW (Fig. 1c). Cells maintained at 37C
exhibited no luciferase activity over background (Fig. 1c),
while TW induced the activity of the HSPmin-Luc reporter by
up to 12-fold (Fig. 1d). Importantly, exposure of the HSPmin-
Luc reporter cell lines to hypoxic conditions for 24 hr elicited
no increase in luciferase reporter activity (Fig. 1d), although
the same conditions led to a massive increase in the activity of
a reporter driven by hypoxia response elements (Supporting
Information Fig. S1), demonstrating that the HSPmin pro-
moter element is not activated by hypoxia. It was also not
induced by other common signals in the tumor microenviron-
ment, including the major inflammatory mediator TNFα and
the key lymphangiogenic factor VEGF-C (Supporting Infor-
mation Fig. S2). Furthermore, TW did not affect the expres-
sion of the epithelial marker E-cadherin or the mesenchymal
marker vimentin, indicating that it does not change general
cellular properties involved in metastasis, such as EMT
(Supporting Information Fig. S3). At the same time, the rat
HSPmin promoter was activated by TW not only in rat ASML
pancreatic carcinoma cells but also in the murine melanoma
cells B16-F10 and the human breast carcinoma cells MCF-7
(Supporting Information Fig. S4), indicating that this system
is applicable across different species and tumor entities.
Next, the ASML-TWIGS cell line was exposed to TW or
hypoxia. In the absence of TW under normoxic conditions,
only EGFP was expressed in these cells. TW induced a switch
from EGFP to mCherry expression in the majority of the cells,
but, importantly, no switch was induced by hypoxia (Fig. 1e),
indicating that the HSPmin promoter element in the TWIGS
system is tightly controlled in the absence of TW.
TW activates the HSPmin element in vivo
To apply local TW to the axillary LNs of rats, a low-efficiency
electric light bulb with an appropriate size and form to fit into
the axilla of the rats was employed. When operated at a con-
stant voltage, the surface temperature of the bulb was stable
after 10 min (Fig. 2a) and proportional to the voltage applied
(Fig. 2b). These data allowed us to establish that the optimal
4 Spatiotemporally controlled induction of gene expression in vivo














temperature for inducing the HSPmin element (43–43.5C)
was achieved by applying a voltage of 63 V. To determine
whether applying the light bulb to the axillary region is suffi-
cient to activate the HSPmin element in vivo, ASML cells
expressing luciferase under the control of the HSPmin element
were injected subcutaneously into the flank of experimental
rats. Once the primary tumor grew and a palpable metastasis in
the axillary LN ipsilateral to the primary tumor was detected,
rats were anesthetized and an electric light bulb at 43.5C was
used to apply TW for 10 min to the ipsilateral axilla (Fig. 2c).
No luciferase activity was detected by bioluminescence imaging
before TW, but 3.5 hr afterward, there was strong luciferase
Figure 1. Legend on next page.
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induction at the site of warming (Fig. 2c). The primary tumor
did not show luciferase activity, indicating that the induction is
tightly regulated, both temporally and spatially, and only occurs
after local TW in vivo.
TW-induced EGFP-mCherry switch in vivo demonstrates a
major contribution of tumor cells trafficking via the
lymphatics to lung metastasis
In a proof of principle experiment, we used ASML cells stably
transfected with the TWIGS constructs to determine the
degree to which cells that traffic via the lymphatics contribute
to lung metastasis formation. After the injection of the
ASML-TWIGS cells subcutaneously into the flank of experi-
mental rats, the ipsilateral or contralateral axillary LNs were
subjected to daily TW until the end of the experiment. Lungs
were then examined for the presence of EGFP+ and mCherry+
metastases on their surface. Metastases derived from tumor
cells that trafficked via the lymph nodes would be expected to
express mCherry, whereas those that disseminated to the lung
directly via the bloodstream should only express EGFP.
TW had no effect on the growth of the primary tumors
(Fig. 3a), nor on the percentage of mCherry+ cells in the pri-
mary tumor (Figs. 2b and 2e). The volume of the tumor-
draining ipsilateral axillary LNs compared to the contralateral
Figure 1. Induction of a genetic switch under the control of a minimal HSP70 promoter by mild transient warming (TW). (a) Schematic
representation of the HSPmin promoter-driven constructs used. HSPmin, minimal promoter of rat heat shock 70 kDa protein 1B (Hspa1b),
containing a single heat shock response element; IRES, internal ribosome entry site; CMV IE/β-actin, cytomegalovirus immediate early and
chicken β-actin promoter; TWIGS, transient warmth-inducible genetic switch system. (b) ASML, MT450 and MTLy cells stably expressing the
indicated constructs were exposed to the indicated temperatures for 10 min. Three hours later, the cells were lysed and a luciferase assay
was performed. (c) ASML cells stably expressing the indicated constructs were exposed to TW at 43.5C in a 96-well plate in a water bath for
25 min (+TW). Control cells (−TW) were left untreated. Subsequently, luciferin was added to the plate and the luciferase activity was
measured every 15 min for 24 hr. (d) ASML, MT450 and MTLy cells stably expressing HSPmin-Luc were cultured for 24 hr at 37C under
normoxia or hypoxia (0.1% O2) or were exposed to 43.5C under normoxia for 10 min (TW) followed by cultivation under normoxia and 37C
for additional 3.5 hr. Subsequently, the cells were lysed and a luciferase assay was performed. (e) ASML cells stably expressing the TWIGS
constructs were cultured at 37C under normoxia or hypoxia (0.1% O2) for 48 hr. To induce TW, the cells were exposed to 43.5C under
normoxia for 10 min, followed by cultivation under 37C and normoxia for 48 hr. At the end of the experiment, the cells were imaged by
fluorescence microscopy. Scale bar, 50 μm. [Color figure can be viewed at wileyonlinelibrary.com]
Figure 2. Induction of gene expression by TW in vivo. (a) The voltage of a Barthelme R1654 light bulb was first raised from 0 to 50 V and
subsequently increased in 10 V steps as indicated. The surface temperature of the bulb was measured at different time points after raising
the temperature to determine the kinetics of warming. A stable temperature was reached at all voltages after 10 min. (b) The surface
temperature of the light bulb was measured 10 min after application of the indicated constant voltages. The measurement showed a very
good fit (R2 = 0.9982) with a linear function, described by the equation shown. (c) ASML cells expressing luciferase under the control of the
HSPmin element were transplanted subcutaneously in BDX rats. After the primary tumor had grown and palpable metastases in the ipsilateral
lymph node were detected, the animals were imaged by bioluminescence (left). Subsequently, the axilla was exposed to TW by applying an
electric bulb at 63 V (43.5C) for 10 min (middle); 3.5 hr later, the animals were injected with luciferin (i.p.) and bioluminescence imaging
was performed (right). [Color figure can be viewed at wileyonlinelibrary.com]
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Figure 3. Evaluation of the contribution of tumor cells that traffic through LNs to lung metastasis. Rats were subcutaneously transplanted with
ASML cells stably expressing the TWIGS constructs. Animals were either left untreated (no TW), or the lymph nodes in the contralateral
(TW contra) or ipsilateral axilla (TW ipsi) were subjected to TW for 10 min daily until the end of the experiment 32 days later. (a and b)
Primary tumor volume (a) and percentage of mCherry positive cells in the primary tumor (b) in the three groups (n = 8). (c) Weight of
ipsilateral and contralateral LNs in the three groups (n = 8). (d) Number of metastases that contain EGFP-positive cells only (EGFP+) and
metastases that contain mCherry-positive cells (mCherry+) in the three groups. **p < 0.01; ***p < 0.001, n.s., not significant, based on Chi-
square tests between the indicated groups. (e) Immunofluorescence staining for EGFP and mCherry in primary tumors (PT), ipsilateral LNs and
lungs of rats from the three groups. Scale bar, 100 μm. [Color figure can be viewed at wileyonlinelibrary.com]
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nodes (Fig. 3c), as well as the number of surface lung metasta-
ses (Fig. 3d) was similar between the groups, indicating that
TW did not affect the incidence of metastasis. However, the
number of mCherry-positive metastases in the lungs of ani-
mals treated with TW on the ipsilateral side was significantly
higher than that observed in animals that were untreated with
TW or which received TW on the contralateral side (Figs. 3d
and 3e, Supporting Information Table S1). Animals that were
untreated or treated with TW on the contralateral side showed
mCherry+ cells in 10 and 21% of lung metastases, respectively
(Fig. 3d). In contrast, 70% of the lung metastases in animals
treated with TW on the ipsilateral contained mCherry+ cells.
These data allowed us to estimate that in this model at least
49% of metastases developing in the lung were seeded by cells
that had trafficked via the axillary LNs draining the primary
tumor.
Discussion
Here we report the establishment of a tightly spatiotemporally
controlled inducible genetic switch system, which allowed us
to assess the contribution of tumor cell trafficking through the
lymphatic system to the seeding of distant metastases. We
developed a promoter element with very low basal activity
that is specifically activated in a strong and sustained manner
by mild TW, but not by a range of other factors in the tumor
microenvironment, allowing controlled spatiotemporal induc-
tion of gene expression in vivo through localized time-
restricted warming of tissues. The genetic switch we developed
with this element should be applicable to a variety of biologi-
cal and medical questions in diverse model systems that
require specific inducible marking of defined populations of
cells in living organisms, for example, for lineage tracing and
the tracking of migratory cells. Our TW approach can be
adapted to other animal models or anatomic locations, for
example, by using alternative heat sources or methods such as
focused ultrasound, which allows warming deep tissues.
To date, only circumstantial evidence exists regarding the
relative contribution of the blood and lymphatic conduits to
metastatic dissemination. Comparative analysis of the genetic
evolution of primary tumors and their metastases can be used
to determine the relationship between LN metastases and
metastases in other organs, and thus by inference the route of
dissemination, but such analyses have resulted in partially
contradictory conclusions. For example, analysis of somatic
variants in hypermutable DNA regions suggests that the
majority of metastases in LNs and distant organs arise
independently,21 whereas whole-genome sequencing suggests
that significant metastasis-to-metastasis spreading occurs,
including from LNs.22 A recent report used a photoconvertible
fluorescent protein to demonstrate that tumor cells passing
through LNs can be detected in the circulation and in the
lungs of experimental animals.4 However, the short-lived
nature of the photoconverted proteins precludes the tracing of
the cells beyond a period of a few days, and thus does not
allow their survival and proliferation in distant organs to be
determined, nor their ability to establish overt, clinically rele-
vant metastases. In contrast, our approach ensures permanent
genetic labeling of the target cells, enabling them to be traced
over extended periods to dissect their contribution to all stages
of the metastatic process.
We found that around half of lung metastases that were
seeded by subcutaneous tumors were derived from cells that
had trafficked through the regional LNs draining the tumor.
This is likely to be an underestimate, as it can take as little as
6 hr for disseminating tumor cells to transit through LNs,23
and thus TW for 10 min per day likely impacted on a sub-
stantial proportion, but not all of the tumor cells disseminat-
ing via the lymphatic route.
A significant fraction of lung metastases that developed
after TW of the ipsilateral axillary LN draining primary
tumors contained both red and green cells. This is likely due
to stable integration of multiple copies of the floxed EGFP-
mCherry reporter construct, some of which switched in
response to TW, and some of which did not, due to the tran-
sient expression of Cre recombinase. Accordingly, metastases
with both red and green cells were considered to have been
derived from disseminating cells that switched in response to
TW of the LNs. The larger fraction of mCherry+ metastases in
animals that received TW on the contralateral side, compared
to animals without TW, can most probably be explained by
induction of the genetic switch in tumor cells trafficking
through blood vessels in the immediate vicinity of the area
exposed to TW. To account for this effect, we based our esti-
mate of the fraction of cells trafficking through the lymphatics
on the difference in mCherry+ metastases between the contra-
lateral and ipsilateral TW groups.
Our work provides direct evidence that the lymphatic vas-
culature can represent a major conduit for disseminating
tumor cells that ultimately seed metastases in the lungs. This
observation has potential clinical implications. For example, if
a significant proportion of metastases are seeded by tumor cells
that traffic via the lymphatics rather than via the bloodstream,
then inhibiting tumor-induced lymphangiogenesis may be
effective in blocking metastasis formation in vital organs. Nev-
ertheless, we note that suppression of lymphangiogenesis in a
model of colorectal cancer metastasis inhibited LN metastasis
formation, but did not impact on liver metastasis formation,
suggesting that the hematogenous route predominates in this
model.24 Similarly, specific suppression of the outgrowth of
LN metastases did not inhibit lung metastasis formation in a
breast cancer model.25 Thus, the relative contribution of
lymphogenous and hematogenous dissemination routes may
vary between different types of cancer and/or depend on the
exact location of the primary tumor. Future applications of the
genetic marking system we present here can address these
issues.
8 Spatiotemporally controlled induction of gene expression in vivo
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